Showing 141-150 of 9443 results for "".
- Merz Aesthetics Announces FDA Clearance of Ultherapy PRIME for Knee Skin Laxityhttps://practicaldermatology.com/news/merz-aesthetics-announces-fda-clearance-of-ultherapy-prime-for-knee-skin-laxity/2488072/The US Food and Drug Administration (FDA) has cleared Ultherapy PRIME (Merz Aesthetics) to improve the appearance of skin laxity on the knees, according to an announcement from the company. Merz Aesthetics said the clearance makes Ultherapy PRIME the first energy-based aesthetic device wit
- New Photoimmunotherapy Approach Targets T Cells and Tumor Antigenshttps://practicaldermatology.com/news/study-new-photoimmunotherapy-approach-targets-t-cells-and-tumor-antigens/2488067/A new activatable photoimmunotherapy platform may enable more selective depletion of pathogenic cells while limiting inflammatory effects associated with existing PIT approaches, according to new research. Photoimmunotherapy
- Study: Reddit Upvotes May Not Reflect Quality of Rosacea Advicehttps://practicaldermatology.com/news/study-reddit-upvotes-may-not-reflect-quality-of-rosacea-advice/2488056/A study of Reddit’s r/Rosacea community examined what users discuss and whether engagement differed according to how closely recommendations aligned with National Rosacea Society (NRS) standard management options. Treatment Experiences Dominate Rosacea Discussions Investigators an
- Fish Oil With Low-Dose Isotretinoin Shows Noninferior Acne Controlhttps://practicaldermatology.com/news/fish-oil-with-low-dose-isotretinoin-shows-noninferior-acne-control/2488054/Fish oil supplementation added to low-dose isotretinoin was noninferior to isotretinoin alone for reducing acne lesions and may help preserve skin hydration and limit increases in triglyceride levels, according to findings published in the
- Abrocitinib Responses Maintained Through Week 72 in JADE REALhttps://practicaldermatology.com/news/abrocitinib-responses-maintained-through-week-72-in-jade-real/2488053/New research suggests that flexible abrocitinib dosing under conditions designed to simulate clinical practice was associated with improvements through Week 72 among observed patients with moderate-to-severe atopic dermatitis (AD). Researchers for the JADE REAL trial enrolled 312 patients
- FDA Approves Tudriqev Plus Nivolumab for Advanced Melanomahttps://practicaldermatology.com/news/fda-approves-tudriqev-plus-nivolumab-for-advanced-melanoma/2488043/The FDA has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg; Replimune, Inc.) in combination with nivolumab for adults with unresectable advanced cutaneous melanoma whose disease progressed on a programmed death receptor-1 (PD-1)–blocking antibody-based regimen, according
- Adalimumab Leads Cost-Efficiency Analysis of Approved HS Biologics Across Five Countrieshttps://practicaldermatology.com/news/adalimumab-leads-cost-efficiency-analysis-of-approved-hs-biologics-across-five-countries/2488023/Adalimumab offers the most favorable balance of cost and clinical efficacy among currently approved monoclonal antibody therapies for moderate-to-severe hidradenitis suppurativa (HS), according to a new economic evaluation in JAM
- ASDS Launches Financial, Technology Retreat for Dermatologistshttps://practicaldermatology.com/news/asds-launches-financial-technology-retreat-for-dermatologists/2488019/The American Society for Dermatologic Surgery (ASDS) is broadening its educational portfolio with the debut of $kin in the Game, a new financial and technology literacy retreat designed exclusively for dermatologists. The two-day program, developed in collaboration with Wilmington Trust,
- Early-Life Respiratory Infections Linked to Higher Risk of Childhood Atopic Dermatitishttps://practicaldermatology.com/news/early-life-respiratory-infections-linked-to-higher-risk-of-childhood-atopic-dermatitis/2488018/Children who experience a greater burden of respiratory infections during the first 3 years of life may face an increased risk of developing atopic dermatitis (AD), according to new research in JAMA Dermatology.
- Study Validates Rapid Screening Tool for Plastic Surgery Meta-analyseshttps://practicaldermatology.com/news/study-validates-rapid-screening-tool-for-plastic-surgery-meta-analyses/2488009/A newly published study suggests that a simple three-question screening tool may help clinicians quickly identify low-quality meta-analyses without relying on lengthy methodological assessments. In a study published in the